United States News All stories

Cheche Group (NASDAQ:CCG) reported its unaudited financial results for the second half and full year ended December 31, 2025, on Thursday, April 2, 2026.

Futu Holdings (NASDAQ:FUTU) announced on Thursday, April 2, 2026, that its board of directors has approved a significant cash dividend, signaling strong confidence in the company’s capital position following a historic 2025 fiscal year.

Priovant Therapeutics, a majority-owned subsidiary of Roivant Sciences (NASDAQ:ROIV), provided a significant update on its late-stage immunology pipeline on Thursday, April 2, 2026.

Roivant Sciences (NASDAQ:ROIV) provided a comprehensive clinical and regulatory update on Thursday, April 2, 2026, revealing a bifurcated path for its most advanced autoimmune programs.

Immunovant (NASDAQ:IMVT) announced topline results from two Phase 3 clinical studies evaluating batoclimab in patients with active, moderate-to-severe thyroid eye disease (TED) on Thursday, April 2, 2026.

Dogness (NASDAQ:DOGZ) reported its financial results for the six months ended December 31, 2025, on Thursday, April 2, 2026.

Faraday Future Intelligent Electric (NASDAQ:FFAI) announced its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, April 2, 2026.

DuPont (NYSE:DD) announced the successful completion of the divestiture of its Aramids business to Arclin on Wednesday, April 1, 2026.

Conagra Brands (NYSE:CAG) reported financial results for the third quarter of fiscal 2026, ended February 22, 2026, on Wednesday, April 1.

Axsome Therapeutics (NASDAQ:AXSM) announced on Wednesday, April 1, 2026, that it has acquired exclusive global rights to balipodect (formerly TAK-063) from Takeda Pharmaceutical Company.

Target Hospitality (NASDAQ:TH) announced on Wednesday, April 1, 2026, a transformative multi-year lease and services agreement to support a "top-five" global hyperscaler in the development of a massive data center campus in North Texas.

Penguin Solutions (NASDAQ:PENG) reported its financial results for the second quarter of fiscal 2026 on Wednesday, April 1.

VSee Health (NASDAQ:VSEE) reported its financial and operational results for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.

WTW (NASDAQ:WTW), a leading global advisory, broking, and solutions company, announced on Wednesday, April 1, 2026, that it has successfully completed the acquisition of FlowStone Partners.

Largo (NASDAQ:LGO) reported its financial and operational results for the fourth quarter and full year ended December 31, 2025, on Wednesday, April 1, 2026.

Eli Lilly and Company (NYSE:LLY) announced on Wednesday, April 1, 2026, that the U.S. Food and Drug Administration (FDA) has approved Foundayo™ (orforglipron) for chronic weight management in adults with obesity, or those who are overweight with at least one weight-related condition.

UniFirst (NYSE:UNF) reported financial results for its second quarter of fiscal 2026, ended February 28, 2026, on Wednesday, April 1.

Lamb Weston Holdings (NYSE:LW) announced its financial results for the third quarter of fiscal 2026 on Wednesday, April 1, 2026.

RenX Enterprises (NASDAQ:RENX) announced its financial results for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.

FitLife Brands (NASDAQ:FTLF) announced its financial results for the fourth quarter and full year ended December 31, 2025, on Wednesday, April 1, 2026. The results highlight a transformative period for the Omaha-based company, largely defined by the successful integration and rapid scaling of the Irwin acquisition.

SES AI (NYSE:SES), a global leader in the development and manufacturing of AI-enhanced high-performance lithium-metal and lithium-ion batteries, provided a robust business update for the first quarter of 2026 on Wednesday, April 1.

Scinai Immunotherapeutics (NASDAQ:SCNI) reported its financial and operational results for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.

TuHURA Biosciences (NASDAQ:HURA) provided a comprehensive corporate and financial update for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.

Home BancShares (NYSE:HOMB), the parent company of Centennial Bank, announced on Wednesday, April 1, 2026, the successful completion of its acquisition of Mountain Commerce Bancorp.